Journal of Medicinal Chemistry · 2005 · 79 citations · 6 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyChemotherapyDrug DiscoveryCytotoxic ChemotherapyOncology PharmacologyAnticancer ActivityAntiproliferative AgentsAntiproliferative Drug ActionDrug Cytotoxicity TestingMedicinal Chemistry ApplicationsMedicinal Heterocycles
A new series of 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives bearing 2-chloroethylamine or salicylaldehyde (2-hydroxybenzaldehyde) or its Schiff base (after condensation with 2-chloroethylamine) units and having also 2-naphthyl or anthraquinone groups as cosubstituents has been synthesized. The in vitro cytotoxic activity of these compounds against a panel of four cancer cell lines has been studied. Most of the compounds exhibited antiproliferative activity in the range of the international criterion for synthetic agents (4 microg/mL) against the MOLT4, L 1210, HL-60, and P388 cell lines chosen for testing.
6
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Krystyna Brandt, R. Kruszyński, T.J. Bartczak et al. · Inorganica Chimica Acta · 2001 · 106 citations
New dioxytetraethyleneoxy macrocyclic cyclophosphazene derivatives
Krystyna Brandt, Teobald Kupka, Jaroslaw Drodz et al. · Inorganica Chimica Acta · 1995 · 65 citations
Toshihiro Ihara, Shinji Sueda, Akiko Inenaga et al. · Supramolecular chemistry · 1997 · 20 citations